Our paper "Many Needles in a Haystack" has been accepted at ICML 2026 — see you in Seoul! 🇰🇷🧬 CRISPR screens can test thousands of genes, but budgets are tight and hits are rare. Which perturbations should you run next? We frame this as a lab-in-the-loop design problem: AI proposes a batch → lab runs it → readouts update the model → repeat. Each cycle gets smarter about where hits are hiding. Our method, Probability-of-Hit, recovers more hits across 5 real immunology screens. More hits per plate, fewer wasted wells. Great work by Andrea Rubbi, Arpit Merchant, Samuel Ogden, Amir Akbarnejad, with Pietro Lio & Sattar Vakili 🎉 #ICML2026 #ActiveLearning #PerturbSeq #FunctionalGenomics #CRISPRscreen #LabInTheLoop #AI4Science #BayesianOptimization

깅코 ( $DNA )의 의미있는 행보를 타임라인으로 정리했다. —— 2024.02 Technology Network 출범. 25개 이상 파트너사와 AI-실험 연결 생태계 구축 선언. 2025.07 DOE 산하 PNNL과 $4.66M 계약 체결. RAC 기반 자율실험실(AMP2) 구축 착수. 2025.12 PNNL 2차 계약. 최대 $47M, 4년. RAC 97대, 분석 기기 100개 이상. Genesis Mission 행정명령 첫 번째 실행 사례. 2026.01 AMP2 공식 가동. 지금 이 순간에도 돌아가고 있다. 2026.02 OpenAI × 깅코. GPT-5 자율실험실. 36,000개 실험, 단백질 합성 비용 40% 절감. 2026.03 Cloud Lab 출시. 웹 브라우저로 자율실험실 접속. 실험 1건 $39부터. 2026.04 AWS Amazon Bio Discovery 출시. wet-lab 자동화 파트너로 깅코 편입. —— 민간 빅테크와 미국 연방정부가 같은 실험 인프라 위에서 돌아간다. 아무도 주목하지 않고 인기 없는 종목이지만, 회사는 부지런히 앞길을 개척 중. 저 뒤로 더 얼마나 의미있는 소식이 들려올지👀👀 #DrugDiscovery #Bioeconomy #GenesisMission #AWS #OpenAI #LabInTheLoop

Aurelien Personnaz et al.: AXIS: a Lab-in-the-Loop machine learning approach for automated detection of macromolecular crystals #StructuralBiology #AI #LabInTheLoop ... #IUCr journals.iucr.org/paper?S205…

"But again, we're seeing this feedback loop and flywheel effect. So more diagnostics means more data, and triangulating this data with the health information of the patient feeds back to the algorithm to make the diagnostics more effective. One of our portfolio holdings companies, a diagnostics company called ChinDX, believes that this combination, this data set of, in that case, genetic testing, and the data about the patients and their lineage is their main competitive advantage, their main mode." Mikhail Zverev discusses further in the short clip below 👇 Tune into the full discussion: "Lab in the loop" and the acceleration in life sciences innovation 👉lnkd.in/eAdFV5mi ⚠️ Warning: Capital at Risk. Professional Investors Only. #AmatiGlobal #innovation #healthcare #investing #investment #fundmanager #labintheloop #clinicaltrials #diagnostics #wealthmanagement #assetmanagement #fundresearch #globalequities #lifesciences

Lab-in-the-Loop drug discovery is becoming real-time and multimodal. BrainStorm Therapeutics blends organoids AI to map brain disease, repurposing an Alzheimer’s drug for Rett syndrome in 9 months. The Playbook: start with human biology -> learn with AI -> validate in tight experimental loops #LabInTheLoop

“This is the future of what drug discovery will look like: This tight coupling of real-world experimentation with these emerging techniques in #ML.” Benchling customer @RelationRx is truly at the forefront of the #biotech #AI revolution. #LabInTheLoop endpts.com/relation-raises-3…